Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Nov 1;359(Pt 3):485–496. doi: 10.1042/0264-6021:3590485

LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1.

R Weiskirchen 1, M Moser 1, S Weiskirchen 1, M Erdel 1, S Dahmen 1, R Buettner 1, A M Gressner 1
PMCID: PMC1222169  PMID: 11672422

Abstract

Activation of hepatic stellate cells is considered to be the main step in the development of liver fibrosis, which is characterized by the transition of quiescent vitamin-A-rich cells to proliferative, fibrogenic and contractile myofibroblasts. The identification of regulatory genes during early cell activation and transdifferentiation is essential to extend our knowledge of hepatic fibrogenesis. In liver, the gene CSRP2 is exclusively expressed by stellate cells, whereas no transcripts are detectable in hepatocytes, sinusoidal endothelial cells or Kupffer cells. The early activation of stellate cells induced by platelet-derived growth factor is accompanied by an enhanced expression of CSRP2. During later stages of transdifferentiation, the expression of CSRP2 in these cells is suppressed in vitro and in vivo. The CSRP2-encoded cysteine- and glycine-rich double-LIM-domain protein (CRP)2 is proposed to function as a molecular adapter, arranging two or more as yet unidentified protein constituents into a macromolecular complex. To identify these proteins and assign a cellular function to CRP2, a human cDNA library was screened with full-length CRP2 as bait in a yeast two-hybrid screen. The protein inhibitor of activated STAT1 ('PIAS1') was shown to associate selectively with the C-terminal LIM domain of CRP2. Physical interaction of both proteins in the cellular environment was confirmed by co-localization experiments with confocal laser scanning microscopy and co-immunoprecipitation analysis. These results establish CRP2 as a potential new factor in the JAK/STAT-signalling pathway and suggest that the suppression of CSRP2 might be a prerequisite for the myofibroblastic transition of hepatic stellate cells.

Full Text

The Full Text of this article is available as a PDF (554.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arber S., Caroni P. Specificity of single LIM motifs in targeting and LIM/LIM interactions in situ. Genes Dev. 1996 Feb 1;10(3):289–300. doi: 10.1101/gad.10.3.289. [DOI] [PubMed] [Google Scholar]
  2. Arber S., Halder G., Caroni P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell. 1994 Oct 21;79(2):221–231. doi: 10.1016/0092-8674(94)90192-9. [DOI] [PubMed] [Google Scholar]
  3. Arber S., Hunter J. J., Ross J., Jr, Hongo M., Sansig G., Borg J., Perriard J. C., Chien K. R., Caroni P. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 1997 Feb 7;88(3):393–403. doi: 10.1016/s0092-8674(00)81878-4. [DOI] [PubMed] [Google Scholar]
  4. Brent R., Finley R. L., Jr Understanding gene and allele function with two-hybrid methods. Annu Rev Genet. 1997;31:663–704. doi: 10.1146/annurev.genet.31.1.663. [DOI] [PubMed] [Google Scholar]
  5. Estojak J., Brent R., Golemis E. A. Correlation of two-hybrid affinity data with in vitro measurements. Mol Cell Biol. 1995 Oct;15(10):5820–5829. doi: 10.1128/mcb.15.10.5820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Flick M. J., Konieczny S. F. The muscle regulatory and structural protein MLP is a cytoskeletal binding partner of betaI-spectrin. J Cell Sci. 2000 May;113(Pt 9):1553–1564. doi: 10.1242/jcs.113.9.1553. [DOI] [PubMed] [Google Scholar]
  7. Friedman S. L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000 Jan 28;275(4):2247–2250. doi: 10.1074/jbc.275.4.2247. [DOI] [PubMed] [Google Scholar]
  8. Gietz D., St Jean A., Woods R. A., Schiestl R. H. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 1992 Mar 25;20(6):1425–1425. doi: 10.1093/nar/20.6.1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Greenwel P., Rubin J., Schwartz M., Hertzberg E. L., Rojkind M. Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. Lab Invest. 1993 Aug;69(2):210–216. [PubMed] [Google Scholar]
  10. Gressner A. M., Lotfi S., Gressner G., Haltner E., Kropf J. Synergism between hepatocytes and Kupffer cells in the activation of fat storing cells (perisinusoidal lipocytes). J Hepatol. 1993 Aug;19(1):117–132. doi: 10.1016/s0168-8278(05)80185-0. [DOI] [PubMed] [Google Scholar]
  11. Gressner A. M. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int Suppl. 1996 May;54:S39–S45. [PubMed] [Google Scholar]
  12. Gyuris J., Golemis E., Chertkov H., Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell. 1993 Nov 19;75(4):791–803. doi: 10.1016/0092-8674(93)90498-f. [DOI] [PubMed] [Google Scholar]
  13. Heldin C. H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999 Oct;79(4):1283–1316. doi: 10.1152/physrev.1999.79.4.1283. [DOI] [PubMed] [Google Scholar]
  14. Hill J., Donald K. A., Griffiths D. E., Donald G. DMSO-enhanced whole cell yeast transformation. Nucleic Acids Res. 1991 Oct 25;19(20):5791–5791. doi: 10.1093/nar/19.20.5791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ito H., Fukuda Y., Murata K., Kimura A. Transformation of intact yeast cells treated with alkali cations. J Bacteriol. 1983 Jan;153(1):163–168. doi: 10.1128/jb.153.1.163-168.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jain M. K., Fujita K. P., Hsieh C. M., Endege W. O., Sibinga N. E., Yet S. F., Kashiki S., Lee W. S., Perrella M. A., Haber E. Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells. J Biol Chem. 1996 Apr 26;271(17):10194–10199. doi: 10.1074/jbc.271.17.10194. [DOI] [PubMed] [Google Scholar]
  17. Jain M. K., Kashiki S., Hsieh C. M., Layne M. D., Yet S. F., Sibinga N. E., Chin M. T., Feinberg M. W., Woo I., Maas R. L. Embryonic expression suggests an important role for CRP2/SmLIM in the developing cardiovascular system. Circ Res. 1998 Nov 16;83(10):980–985. doi: 10.1161/01.res.83.10.980. [DOI] [PubMed] [Google Scholar]
  18. Knook D. L., Blansjaar N., Sleyster E. C. Isolation and characterization of Kupffer and endothelial cells from the rat liver. Exp Cell Res. 1977 Oct 15;109(2):317–329. doi: 10.1016/0014-4827(77)90011-8. [DOI] [PubMed] [Google Scholar]
  19. Kong Y., Flick M. J., Kudla A. J., Konieczny S. F. Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD. Mol Cell Biol. 1997 Aug;17(8):4750–4760. doi: 10.1128/mcb.17.8.4750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Konrat R., Kräutler B., Weiskirchen R., Bister K. Structure of cysteine- and glycine-rich protein CRP2. Backbone dynamics reveal motional freedom and independent spatial orientation of the lim domains. J Biol Chem. 1998 Sep 4;273(36):23233–23240. doi: 10.1074/jbc.273.36.23233. [DOI] [PubMed] [Google Scholar]
  21. Kountouras J., Billing B. H., Scheuer P. J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 1984 Jun;65(3):305–311. [PMC free article] [PubMed] [Google Scholar]
  22. Leaman D. W., Leung S., Li X., Stark G. R. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J. 1996 Dec;10(14):1578–1588. [PubMed] [Google Scholar]
  23. Liao J., Fu Y., Shuai K. Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5267–5272. doi: 10.1073/pnas.97.10.5267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liebhaber S. A., Emery J. G., Urbanek M., Wang X. K., Cooke N. E. Characterization of a human cDNA encoding a widely expressed and highly conserved cysteine-rich protein with an unusual zinc-finger motif. Nucleic Acids Res. 1990 Jul 11;18(13):3871–3879. doi: 10.1093/nar/18.13.3871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Liu B., Liao J., Rao X., Kushner S. A., Chung C. D., Chang D. D., Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10626–10631. doi: 10.1073/pnas.95.18.10626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Loo D. T., Kanner S. B., Aruffo A. Filamin binds to the cytoplasmic domain of the beta1-integrin. Identification of amino acids responsible for this interaction. J Biol Chem. 1998 Sep 4;273(36):23304–23312. doi: 10.1074/jbc.273.36.23304. [DOI] [PubMed] [Google Scholar]
  27. Louis H. A., Pino J. D., Schmeichel K. L., Pomiès P., Beckerle M. C. Comparison of three members of the cysteine-rich protein family reveals functional conservation and divergent patterns of gene expression. J Biol Chem. 1997 Oct 24;272(43):27484–27491. doi: 10.1074/jbc.272.43.27484. [DOI] [PubMed] [Google Scholar]
  28. Oberst C., Hartl M., Weiskirchen R., Bister K. Conditional cell transformation by doxycycline-controlled expression of the MC29 v-myc allele. Virology. 1999 Jan 20;253(2):193–207. doi: 10.1006/viro.1998.9499. [DOI] [PubMed] [Google Scholar]
  29. Pinzani M., Gesualdo L., Sabbah G. M., Abboud H. E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest. 1989 Dec;84(6):1786–1793. doi: 10.1172/JCI114363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pinzani M., Knauss T. C., Pierce G. F., Hsieh P., Kenney W., Dubyak G. R., Abboud H. E. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am J Physiol. 1991 Mar;260(3 Pt 1):C485–C491. doi: 10.1152/ajpcell.1991.260.3.C485. [DOI] [PubMed] [Google Scholar]
  31. Pinzani M., Marra F., Carloni V. Signal transduction in hepatic stellate cells. Liver. 1998 Feb;18(1):2–13. doi: 10.1111/j.1600-0676.1998.tb00120.x. [DOI] [PubMed] [Google Scholar]
  32. Pomiès P., Louis H. A., Beckerle M. C. CRP1, a LIM domain protein implicated in muscle differentiation, interacts with alpha-actinin. J Cell Biol. 1997 Oct 6;139(1):157–168. doi: 10.1083/jcb.139.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ranganna K., Yatsu F. M. Inhibition of platelet-derived growth factor BB-induced expression of glyceraldehyde-3-phosphate dehydrogenase by sodium butyrate in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3420–3427. doi: 10.1161/01.atv.17.12.3420. [DOI] [PubMed] [Google Scholar]
  34. Sadler I., Crawford A. W., Michelsen J. W., Beckerle M. C. Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J Cell Biol. 1992 Dec;119(6):1573–1587. doi: 10.1083/jcb.119.6.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Schiestl R. H., Gietz R. D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet. 1989 Dec;16(5-6):339–346. doi: 10.1007/BF00340712. [DOI] [PubMed] [Google Scholar]
  36. Schmeichel K. L., Beckerle M. C. LIM domains of cysteine-rich protein 1 (CRP1) are essential for its zyxin-binding function. Biochem J. 1998 May 1;331(Pt 3):885–892. doi: 10.1042/bj3310885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schäfer S., Zerbe O., Gressner A. M. The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology. 1987 Jul-Aug;7(4):680–687. doi: 10.1002/hep.1840070411. [DOI] [PubMed] [Google Scholar]
  38. Seglen P. O. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29–83. doi: 10.1016/s0091-679x(08)61797-5. [DOI] [PubMed] [Google Scholar]
  39. Tan J., Hall S. H., Hamil K. G., Grossman G., Petrusz P., Liao J., Shuai K., French F. S. Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis. Mol Endocrinol. 2000 Jan;14(1):14–26. doi: 10.1210/mend.14.1.0408. [DOI] [PubMed] [Google Scholar]
  40. Valdez B. C., Henning D., Perlaky L., Busch R. K., Busch H. Cloning and characterization of Gu/RH-II binding protein. Biochem Biophys Res Commun. 1997 May 19;234(2):335–340. doi: 10.1006/bbrc.1997.6642. [DOI] [PubMed] [Google Scholar]
  41. Vignais M. L., Sadowski H. B., Watling D., Rogers N. C., Gilman M. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol. 1996 Apr;16(4):1759–1769. doi: 10.1128/mcb.16.4.1759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wang X., Lee G., Liebhaber S. A., Cooke N. E. Human cysteine-rich protein. A member of the LIM/double-finger family displaying coordinate serum induction with c-myc. J Biol Chem. 1992 May 5;267(13):9176–9184. [PubMed] [Google Scholar]
  43. Weiskirchen R., Bister K. Suppression in transformed avian fibroblasts of a gene (crp) encoding a cysteine-rich protein containing LIM domains. Oncogene. 1993 Sep;8(9):2317–2324. [PubMed] [Google Scholar]
  44. Weiskirchen R., Erdel M., Utermann G., Bister K. Cloning, structural analysis, and chromosomal localization of the human CSRP2 gene encoding the LIM domain protein CRP2. Genomics. 1997 Aug 15;44(1):83–93. doi: 10.1006/geno.1997.4855. [DOI] [PubMed] [Google Scholar]
  45. Weiskirchen R., Gressner A. M. The cysteine- and glycine-rich LIM domain protein CRP2 specifically interacts with a novel human protein (CRP2BP). Biochem Biophys Res Commun. 2000 Aug 11;274(3):655–663. doi: 10.1006/bbrc.2000.3187. [DOI] [PubMed] [Google Scholar]
  46. Weiskirchen R., Pino J. D., Macalma T., Bister K., Beckerle M. C. The cysteine-rich protein family of highly related LIM domain proteins. J Biol Chem. 1995 Dec 1;270(48):28946–28954. doi: 10.1074/jbc.270.48.28946. [DOI] [PubMed] [Google Scholar]
  47. Zerbe O., Gressner A. M. Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver. Exp Mol Pathol. 1988 Aug;49(1):87–101. doi: 10.1016/0014-4800(88)90023-8. [DOI] [PubMed] [Google Scholar]
  48. de Leeuw A. M., McCarthy S. P., Geerts A., Knook D. L. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology. 1984 May-Jun;4(3):392–403. doi: 10.1002/hep.1840040307. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES